Sandoz Unveils Further Biosimilars Investment

Plans To Spend Around $90m To Build Technical Development Center In Slovenia

$90 million icon in blue
Sandoz is spending around $90m on the new center • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products